Study could lead to an effective new option to reduce the risk of heart attacks and strokes for millions who cannot control ...

Editas Medicine (NASDAQ:EDIT) executives outlined the company’s in vivo CRISPR gene-editing strategy and near-term clinical plans during a recent discussion featuring President and CEO Gilmore O’Neill ...

Despite decades of study, a pharmacopoeia of medicines, and untold millions in pharmaceutical research, heart disease remains the leading cause of death around the world. Excess cholesterol in ...

Peter Attia warns that simplicity is crushing nuance in science. I agree—so I took a closer look at his own argument on LDL, ...

Professor Gilbert Thompson, who has died aged 93, played a leading role in showing how “bad” cholesterol (low-density lipoprotein or LDL cholesterol) is processed by the body and how faults in this ...

PHILADELPHIA ­— Ten patients enrolled in the experimental drug trial, and they were the sickest of the sick. All had a genetic disorder that cranks up levels of LDL cholesterol in the blood. Known as ...

Please provide your email address to receive an email when new articles are posted on . CETP inhibition may help high-risk patients reach their LDL goals and reduce risk for atherosclerotic CVD events ...